Chemotherapy for Malignant Gliomas of the Brain: a Review of Ten-years Experience

Overview

Journal Acta Neurochir (Wien)

Specialty Neurosurgery

Date 1990 Jan 1

PMID 2360465

Citations 7

Authors

P Paoletti

G Butti

R Knerich

P Gaetani

R Assietti

Affiliations

Soon will be listed here.

Abstract

In recent years, there has been a great improvement in the knowledge of the biological aspects of malignant gliomas of the brain. Conversely, there has been an increase of interest in the multimodal treatment of these tumours. In this review, we have analyzed the results of the several reports which have appeared in the literature that deal with the chemotherapeutic treatment of malignant gliomas. Furthermore, some areas of biological investigation that could have an impact on pharmacological therapy are discussed.

Citing Articles

Regulation of Inflammatory and Proliferative Pathways by Fotemustine and Dexamethasone in Endometriosis.

Genovese T, Siracusa R, DAmico R, Cordaro M, Peritore A, Gugliandolo E Int J Mol Sci. 2021; 22(11).

PMID: 34206129 PMC: 8199515. DOI: 10.3390/ijms22115998.

ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.

Gwak H, Youn S, Kwon A, Lee S, Kim J, Rhee C J Neurooncol. 2005; 75(2):173-80.

PMID: 16132508 DOI: 10.1007/s11060-005-1858-8.

High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.

Albrecht K, de Witt Hamer P, Leenstra S, Bakker P, Beijnen J, Troost D J Neurooncol. 2001; 53(3):267-71.

PMID: 11718259 DOI: 10.1023/a:1012287212388.

Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.

Assietti R, Olson J J Neurooncol. 1996; 27(3):251-8.

PMID: 8847559 DOI: 10.1007/BF00165482.

Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.

Matsutani M, Nakamura O, Nakamura M, Nagashima T, Asai A, Fujimaki T J Neurooncol. 1994; 19(3):227-37.

PMID: 7807173 DOI: 10.1007/BF01053276.

References

Morten J, Margison G . Increased O6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis. 1988; 9(1):45-9. DOI: 10.1093/carcin/9.1.45. View

Chamberlain M, PRADOS M, Silver P, Levin V . A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors. J Neurooncol. 1988; 6(4):319-23. DOI: 10.1007/BF00177426. View

Tirelli U, DIncalci M, Canetta R, Tumolo S, Franchin G, Veronesi A . Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol. 1984; 2(5):432-7. DOI: 10.1200/JCO.1984.2.5.432. View

Maral J, Poisson M, Pertuiset B, Mashaly P, Weil M, JACQUILLAT C . Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma. J Neurooncol. 1985; 3(3):245-9. DOI: 10.1007/BF00165185. View

Hatlevoll R, Lindegaard K, Hagen S, Kristiansen K, Nesbakken R, TORVIK A . Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter.... Cancer. 1985; 56(1):41-7. DOI: 10.1002/1097-0142(19850701)56:1<41::aid-cncr2820560108>3.0.co;2-w. View

Nagashima T, Hoshino T, Cho K, Senegor M, Waldman F, Nomura K . Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors. J Neurosurg. 1988; 68(3):388-92. DOI: 10.3171/jns.1988.68.3.0388. View

Walker M, Green S, Byar D, ALEXANDER Jr E, Batzdorf U, Brooks W . Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980; 303(23):1323-9. DOI: 10.1056/NEJM198012043032303. View

Green S, Byar D, Walker M, Pistenmaa D, ALEXANDER Jr E, Batzdorf U . Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983; 67(2):121-32. View

Hochberg F, Parker L, Takvorian T, Canellos G, Zervas N . High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg. 1981; 54(4):455-60. DOI: 10.3171/jns.1981.54.4.0455. View

10.

LOEW F, Papavero L . The intraarterial route of drug delivery in the chemotherapy of malignant brain tumours. Adv Tech Stand Neurosurg. 1988; 16:51-79. DOI: 10.1007/978-3-7091-6954-4_2. View

11.

Rosenblum M, Gerosa M . Stem cell sensitivity. Prog Exp Tumor Res. 1984; 28:1-17. View

12.

Eagan R, CHILDS Jr D, Layton Jr D, Laws Jr E, Bisel H, HOLBROOK M . Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma. JAMA. 1979; 241(19):2046-50. View

13.

MAHALEY Jr M, WHALEY R, Krigman M, Bouldin T, BERTSCH L, Cush S . Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas. Surg Neurol. 1987; 27(5):430-2. DOI: 10.1016/0090-3019(87)90248-5. View

14.

Wolff S, Phillips G, Herzig G . High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Cancer Treat Rep. 1987; 71(2):183-5. View

15.

Stewart D, OBRYAN R, Al-Sarraf M, COSTANZI J, Oishi N . Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study. J Neurooncol. 1983; 1(2):145-7. DOI: 10.1007/BF00182960. View

16.

Brufman G, Halpern J, Sulkes A, Catane R, BIRAN S . Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors. Oncology. 1984; 41(4):239-41. DOI: 10.1159/000225830. View

17.

Nelson D, Schoenfeld D, Weinstein A, Nelson J, Wasserman T, Goodman R . A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study. Int J Radiat Oncol Biol Phys. 1983; 9(8):1143-51. DOI: 10.1016/0360-3016(83)90172-4. View

18.

Andersen J, Christensen L, Kongsholm H . Phase II trial of prednimustine in glioblastoma multiforme. Cancer Treat Rep. 1984; 68(5):795-7. View

19.

Ushio Y, Hayakawa T, Hasegawa H, Yamada K, Arita N . Chemotherapy of malignant gliomas. Neurosurg Rev. 1984; 7(1):3-12. DOI: 10.1007/BF01743285. View

20.

GREENBERG H, ENSMINGER W, Chandler W, Layton P, Junck L, Knake J . Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg. 1984; 61(3):423-9. DOI: 10.3171/jns.1984.61.3.0423. View